Europe - FRA:DC4 - US2521311074 - Common Stock
We assign a fundamental rating of 6 out of 10 to DC4. DC4 was compared to 59 industry peers in the Health Care Equipment & Supplies industry. DC4 scores excellent on profitability, but there are some minor concerns on its financial health. DC4 is valued quite expensively, but it does show have an excellent growth rating. With these ratings, DC4 could be worth investigating further for growth investing!.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.8% | ||
ROE | 22.21% | ||
ROIC | 14.52% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 17.22% | ||
PM (TTM) | 13.29% | ||
GM | 60.01% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.5 | ||
Debt/FCF | 4.38 | ||
Altman-Z | 4.96 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.52 | ||
Quick Ratio | 1.35 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 42.1 | ||
Fwd PE | 27.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 49.02 | ||
EV/EBITDA | 25.34 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
FRA:DC4 (10/22/2025, 7:00:00 PM)
61.47
+2.27 (+3.83%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 42.1 | ||
Fwd PE | 27.15 | ||
P/S | 6.51 | ||
P/FCF | 49.02 | ||
P/OCF | 28.33 | ||
P/B | 10.87 | ||
P/tB | 11.37 | ||
EV/EBITDA | 25.34 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 7.8% | ||
ROE | 22.21% | ||
ROCE | 18.43% | ||
ROIC | 14.52% | ||
ROICexc | 53.56% | ||
ROICexgc | 59.66% | ||
OM | 17.22% | ||
PM (TTM) | 13.29% | ||
GM | 60.01% | ||
FCFM | 13.27% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.5 | ||
Debt/FCF | 4.38 | ||
Debt/EBITDA | 1.33 | ||
Cap/Depr | 176.58% | ||
Cap/Sales | 9.69% | ||
Interest Coverage | 250 | ||
Cash Conversion | 101.12% | ||
Profit Quality | 99.88% | ||
Current Ratio | 1.52 | ||
Quick Ratio | 1.35 | ||
Altman-Z | 4.96 |